Clinical Trials on Mucolipidosis Type 4

Total 56574 results

Northwestern University
University of Illinois at Chicago

Completed

A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use

Diabetes Mellitus Type II | Diabetes Mellitus Type I

United States
University of Florida

Completed

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Diamontech AG
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Recruiting

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry

Healthy | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 1

Germany
Medtronic Diabetes

Completed

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States, China
University of Aarhus
Aarhus University Hospital

Terminated

In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part A

Diabetes Mellitus | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

Denmark
University of Aarhus
Aarhus University Hospital

Terminated

In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B (INDIGO)

Diabetes Mellitus | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

Denmark
University Health Network, Toronto

Unknown

Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions

Diabetes Mellitus | Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 1

Canada
Medtronic Diabetes

Completed

An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited

Completed

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (HM12460A)

Healthy | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Baylor College of Medicine

Completed

A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes

Diabetes | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Generex Biotechnology Corp.

No longer available

Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus
Integrity Applications Ltd.

Unknown

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device (CR-01-001)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

Israel
Brigham and Women's Hospital

Completed

Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Amgen

Completed

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study (PERSEIDA)

RAS Wild Type mCRC

Spain
University Hospital, Geneva

Completed

Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy

Nightmares, REM-Sleep Type

Switzerland
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients

Type 2 Diabetic Patients
AstraZeneca

Completed

DAPA - Egypt Study

Type-2 Diabetes

Egypt
Emresenocak

Completed

The Effects of Aerobic Exercises on Exercise Capacity in Type-2 Diabetes Mellitus

Type-2 Diabetes

Turkey
Loma Linda University
California Walnut Commission

Terminated

Walnuts and Glucose Variability

Type-2 Diabetes

United States
Barretos Cancer Hospital

Unknown

The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater

Ampulla of Vater Intestinal-Type Adenoma

Brazil
Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Sun Yat-sen University
The First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaborators

Completed

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Bayer

Active, not recruiting

A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D) (START-AM)

Type 2 Diabetes Mellitus

India
Takeda

Completed

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Shanghai HEP Pharmaceutical Co., Ltd.

Withdrawn

A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin

Type 2 Diabetes Patients
Nanjing First Hospital, Nanjing Medical University

Active, not recruiting

Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Microbio Co Ltd

Completed

Postbiotic MBS and Metformin Combination in Patients With T2DM

Type-II Diabetes

Taiwan
Handok Inc.

Completed

Tenelia Elderly CGMS Study(TEDDY)

Type 2 Diabetes Mellitus

Korea, Republic of
Rush University Medical Center

Withdrawn

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit

Type 2 Diabetes Mellitus
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

Germany, United States, Spain, Poland
Ohio University

Withdrawn

WellStart Reboot Study

Type 2 Diabetes Mellitus

United States
KeyBioscience AG
Eli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...

Terminated

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Type II Diabetes Mellitus

Germany
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (LIXILAN JP-O2)

Type 2 Diabetes Mellitus

Japan
AstraZeneca

Completed

Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

Type 2 Diabetes Mellitus

Korea, Republic of
Oramed, Ltd.
Integrium

Completed

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Diabetes Type 2

United States
Antonio Di Mauro

Completed

GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients. (VAS)

Type-2 Diabetes

Italy
Eli Lilly and Company

Completed

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes (IMAGINE 8)

Type 2 Diabetes Mellitus

Germany, United States
University of Oxford
NIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)

Completed

Type 2 Diabetes: Risk Perceptions and Self-management Behaviour

Type 2 Diabetes Mellitus

United Kingdom
Kun-Ho Yoon
Takeda

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK)

Type 2 Diabetes Mellitus

Korea, Republic of
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Type 2 Diabetes Mellitus
University of Palermo
AstraZeneca; University of Catania

Unknown

Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes

Type 2 Diabetes Mellitus

Italy
LG Life Sciences

Completed

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Type 2 Diabetes Mellitus
AstraZeneca

Completed

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Type 2 Diabetes Mellitus

China
Biocon Limited

Completed

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Type 2 Diabetes Mellitus
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
Novartis Pharmaceuticals

Completed

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Type-2 Diabetes Mellitus

Hong Kong
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Type 2 Diabetes Mellitus

Korea, Republic of

3

Subscribe